Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Reexamination Certificate
2006-04-18
2006-04-18
Smith, Lynette R. F. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
C424S268100, C424S265100, C424S199100, C424S190100, C424S185100, C530S350000, C536S023700, C435S320100, C435S173300, C435S069300
Reexamination Certificate
active
07029685
ABSTRACT:
In this application is described the expression and purification of a recombinantPlasmodium falciparum(3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a protein for use alone, or as part of, a vaccine to prevent malaria.
REFERENCES:
patent: 5766597 (1998-06-01), Paoletti et al.
Dutta Sheetij
Lanar David E.
Nair Lalitha P. V.
Ware Lisa A.
Arwine Elizabeth
Baskar Padma
Smith Lynette R. F.
The United States of America as represented by the Secretary of
LandOfFree
Plasmodium falciparum AMA-1 protein and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Plasmodium falciparum AMA-1 protein and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plasmodium falciparum AMA-1 protein and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3542409